Ummeed Child Development Center, Mumbai, India.
Division of Developmental and Behavioral Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA.
J Dev Behav Pediatr. 2022 Jan 1;43(1):32-37. doi: 10.1097/DBP.0000000000000963.
This study aims to describe the extent of telehealth use by global developmental-behavioral pediatrics (DBP) clinicians and barriers (if any) in adopting telehealth during the coronavirus disease 2019 (COVID-19) pandemic.
A survey was disseminated to DBP clinicians through contact with international professional organizations to determine the use of telehealth in DBP care, before and since the beginning of the COVID-19 pandemic. Descriptive statistics and χ2 tests were used for analysis.
A total of 271 respondents from 38 countries completed the survey. The number of respondents offering telehealth increased from 36% to 88% after the pandemic, with the greatest shift to telehealth among high-income countries (HICs). Among respondents using telehealth, 75.1% were conducting interactive video visits, with HICs using more telehealth modalities embedded in electronic health records. Most patients (98.7%) were at home for the telehealth encounter. Almost half (46.5%) could not include an interpreter in telehealth visits. Barriers reported by telehealth users included concerns about limited patient access to technology (74.3%), home environment distractions (56.5%), preference for in-person care (53.6%), telehealth effectiveness (48.1%), workflow efficiency (42.2%), and cost/reimbursement (32.1%).
Global DBP clinicians rapidly adopted telehealth and continued to have interprofessional practice while doing so, with the largest adoption occurring in HICs. Provider concerns about effectiveness and patient access to technology emerged as key organizational and patient barriers, respectively. Increased provider confidence in telehealth and its sustained use in the future depends on supportive regulatory policies and availability and use of measures to monitor quality and effectiveness.
本研究旨在描述全球发育行为儿科学(DBP)临床医生使用远程医疗的程度,以及在 2019 年冠状病毒病(COVID-19)大流行期间采用远程医疗的障碍(如果有)。
通过与国际专业组织联系,向 DBP 临床医生发送了一份调查问卷,以确定 COVID-19 大流行前后 DBP 护理中远程医疗的使用情况。采用描述性统计和 χ2 检验进行分析。
共有来自 38 个国家的 271 名受访者完成了调查。大流行后,提供远程医疗服务的受访者人数从 36%增加到 88%,其中高收入国家(HICs)向远程医疗的转变最大。在使用远程医疗的受访者中,75.1%正在进行互动视频访问,HICs 更多地使用嵌入电子健康记录的远程医疗模式。大多数患者(98.7%)在家中进行远程医疗就诊。近一半(46.5%)的受访者无法在远程医疗就诊中使用口译员。远程医疗用户报告的障碍包括对患者获取技术的有限性的担忧(74.3%)、家庭环境干扰(56.5%)、对面对面护理的偏好(53.6%)、远程医疗的有效性(48.1%)、工作流程效率(42.2%)和成本/报销(32.1%)。
全球 DBP 临床医生迅速采用了远程医疗,并在这样做的过程中继续进行跨专业实践,其中 HICs 的采用程度最大。提供者对有效性和患者获取技术的关注分别成为关键的组织和患者障碍。提供者对远程医疗的信心增强以及未来对其的持续使用取决于支持性的监管政策以及监测质量和有效性的措施的可用性和使用。